US EditionTrump administration cancels $766 million Moderna contract to fight future pandemics, including bird flu
- The Trump administration has canceled a $766 million contract with Moderna for developing a bird flu vaccine, according to the drugmaker's announcement.
- An HHS spokesperson explained that the project did not meet scientific standards or safety expectations for federal investment following a comprehensive internal review.
- Amesh Adalja stated that the cancellation discards a potentially effective tool against avian influenza outbreaks.
- Health Secretary Robert F. Kennedy Jr. Questioned vaccine use and suggested letting bird flu spread among poultry to study resistant chickens.
79 Articles
79 Articles
US government cancels funding to Moderna for its bird flu vaccine
The Trump Administration has halted an award worth $766 million that was intended to support Moderna in the development of a bird flu vaccine. The decision to stop the funding is a significant setback for Moderna's efforts to create a vaccine for the bird flu, and the company has acknowledged the termination of the award.
Omaha World-Herald
Moderna vaccine contract canceled
The Trump administration has canceled a $766 million contract awarded to drugmaker Moderna Inc. to develop a vaccine against potential pandemic influenza viruses, including the H5N1 bird flu.
HHS Cancels Two Contracts Totaling $766 million For Moderna mRNA Bird Flu Vaccines › American Greatness
The Trump administration has reportedly canceled two contracts totaling $776 million to the pharmaceutical company Moderna for the development of a bird flu vaccine for […] Source
Coverage Details
Bias Distribution
- 42% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
